Official 2024 U.S. DOL Form 5500 summary for The Leukemia & Lymphoma Society, INC. 403(b) Plan (The Leukemia & Lymphoma Society, INC. 403(b) Plan · EIN 13-5644916 · PN 002): $134.72M net assets, 1,110 active participants, and $30.57 per $10,000 (30.57 bps).
| Plan Sponsor | The Leukemia & Lymphoma Society, INC. 403(b) Plan |
|---|---|
| Filing Identifier | The Leukemia & Lymphoma Society, INC. 403(b) Plan · EIN 13-5644916 · PN 002 |
| Plan Category & State | 403(b) Tax-Exempt DC (NY) |
| Asset-Size Peer Cohort | $100M-$500M |
| Plan Net Assets (2024) | $134.72M |
| Active Participants | 1,110 |
| Direct Admin Fee Rate | $30.57 per $10,000 (30.57 bps) |
| Cohort Peer Median | $9.75 per $10,000 (9.75 bps) |
| Primary Recordkeeper / Provider | Empower Retirement |
| Schedule H Line 4a Remittance | Schedule H Line 4a Late Remittance Reported ($16,407, often administrative timing) |
Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI